Herpes zoster (HZ) is common in older people, with a lifetime risk of 25%. The main risk factors are advanced age and immunosuppression. People with a rheumatic and musculoskeletal disease have an overall higher risk for shingles.
Recombinant zoster vaccine well tolerated by patients with inflammatory RMD
- Post author:admin
- Post published:June 11, 2025
- Post category:uncategorized